Navigation Links
Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021
Date:12/1/2011

ument Conservation Laboratory (DCL)

Dong-A

DSM Pharmaceuticals

E.R. Squibb & Sons

Eli Lilly and Company

EMD Serono

EnWave Corporation

Eurogentec

European Freeze Dry

European Medicines Agency (EMA)

Famar Health Care Services

Finn-Aqua Santasalo-Sohlberg Corporation

Food and Drug Administration (US FDA)

Formatech

Freeze Dryer Systems Europe

Freezedry Specialties

Fresenius Kabi Product Partnering

Frozen In Time

Gate Pharmaceuticals

GE Healthcare

GEA Lyophil

GEA Niro

GEA Pharma Systems

Genentech

GeneScience

Getz Pharma Research

GIPHARMA

Girindus

Gland Pharma Limited

GlaxoSmithKline

GP Pharm

Grand River Aseptic Manufacturing

Haake Buchler Instruments

Haupt Pharma

HollisterStier Laboratories

Hosokawa Micron Powder Systems

Hospira

HTD Biosystems

Hull

Human Genome Sciences

I.M.A. Industria Macchine Automatiche

IDT Biologika

ilShinBioBase

Immunex Corporation

Intas Biopharmaceuticals

Intelligent Pharma 

Irvine Pharmaceutical Services

Janssen Cilag

JHP Pharmaceuticals

Jubilant Life Sciences

KP Pharmaceutical Technology

Labconco Corporation

Legacy Pharmaceuticals International

Leybold

LG Life Sciences

LifeScientz Bio-tech Co.

Lonza

Lyka Labs

Lyofal

Lyophilization Services of New England

Lyophilization Technology

Martin Christ Gefriertrocknungsanlagen

MechaTech Systems 

Merck & Co.

Merck Sharp & Dohme Corporation

Merk Process

Millrock Technology

Miltenyi Biotec

National Archives and Records Administration (NARA)

Nextar Chempharma Solutions

NextPharma Techno
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021 - What are the Revenue Prospects?
2. Reportlinker Adds Gastrointestinal Pharmaceuticals: Technologies and Markets
3. VIDEO from thenewsmarket.com and Roche Pharmaceuticals: MabThera Approved in Europe for First Line Maintenance Treatment of Follicular Lymphoma, a Common Type of Blood Cancer
4. Reportlinker Adds OTC Pharmaceuticals: Global Industry Almanac
5. Reportlinker Adds Process Analytical Technologies for Pharmaceuticals: Global Markets
6. Novel Technology Breaks Through Cancer Pain
7. CLIA Waiver Submitted for Rapid HIV Test Employs StatSures Barrel Technology
8. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
9. Local Medicare Contractors Expand Hypertension Coverage for CardioDynamics BioZ(R) ICG Technology
10. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
11. Multiple NIH Phase 2 HIV Vaccine Trials Using Vicals Technology Produce Encouraging Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... 23, 2014  SI-BONE, Inc., a medical device company ... ® a minimally invasive surgical (MIS) device indicated ... that the U.S. Patent and Trademark Office has awarded ... for the fixation and fusion of bone.  This newly ... tapered distal end that may be placed from one bone across ...
(Date:9/23/2014)... Sept. 23, 2014 Report Details ... you trends, R&D and predicted revenues Do you ... Now get the latest analysis for those cancer ... opportunities and revenue forecasts. Visiongain,s new report ... kinase inhibition and related technology. There avoid missing ...
(Date:9/23/2014)... , Sept. 23, 2014 EnzymeBioSystems (OTCBB: ... along with the process of evaluating an enzyme ... in fighting tumors. In an effort to evaluate this ... with various contract research organizations to enlist their ... the use of an antitumor natural product called ...
Breaking Medicine Technology:SI-BONE, Inc. Strengthens Patent Portfolio with the U.S. Patent and Trademark Office's Issuance of Threaded, Fenestrated Implant Method Patent 2SI-BONE, Inc. Strengthens Patent Portfolio with the U.S. Patent and Trademark Office's Issuance of Threaded, Fenestrated Implant Method Patent 3Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024 2Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024 3Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024 4Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024 5EnzymeBioSystems Announces Progress with an Enzyme Compound 2
... today reported financial results for the third quarter ended,September ... Novavax reported a net loss of $9.0 million, or ... $5.0 million net loss, or the,equivalent of $0.08 loss ... For the nine months ended September 30, 2007, the ...
... Allos,Therapeutics, Inc. (Nasdaq: ALTH ) today announced ... non-randomized, open-label, multi-center dose,escalation study of the Company,s ... tumors or non-Hodgkin,s lymphoma (NHL). "We are ... said Pablo,J. Cagnoni, M.D., Chief Medical Officer of ...
Cached Medicine Technology:Novavax Reports Third Quarter 2007 Financial Results and Progress with Vaccine Development Programs 2Novavax Reports Third Quarter 2007 Financial Results and Progress with Vaccine Development Programs 3Novavax Reports Third Quarter 2007 Financial Results and Progress with Vaccine Development Programs 4Novavax Reports Third Quarter 2007 Financial Results and Progress with Vaccine Development Programs 5Novavax Reports Third Quarter 2007 Financial Results and Progress with Vaccine Development Programs 6Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non-Hodgkin's Lymphoma 2Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non-Hodgkin's Lymphoma 3Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non-Hodgkin's Lymphoma 4
(Date:9/23/2014)... TUESDAY, Sept. 23, 2014 (HealthDay News) -- A test used ... geographic regions where certain lung infections are more common, a ... lung cancer is through the use of what,s known as ... imaging called FDG-PET is used, according to the study authors. ... do parts of the lungs that don,t have ...
(Date:9/23/2014)... Avid collector Andrew Hawley, from Vintage Rock Posters, ... Seattle concert posters. The Doors were a smash hit after ... The Seattle Eagles Auditorium concert was held on July 23. ... Eagles Auditorium in November the same year. The artist that ... in three colors. The poster is a split fountain silkscreen ...
(Date:9/23/2014)... What: Rutgers Presbyterian Church, a ... that embodies the inclusion and diversity of New ... the Ecological Crisis, a public lecture led by ... of Old Testament at Louisville Presbyterian Seminary. Tull ... lends insight into current ecological problems, including energy ...
(Date:9/23/2014)... A recent Oregon survey about an exercise DVD ... daily routine of elementary school students found it had ... teachers, and offered clear advantages for overly sedentary educational ... and produced by the Healthy Youth Program of the ... available nationally. , Brain Breaks leads children in 5-7 ...
(Date:9/23/2014)... OAK BROOK, Ill. (September 23, 2014) Both ... malignancy with screening computed tomography (CT) colonography greatly ... invasive follow-up tests precipitated by false-positive diagnoses, according ... issue of the journal Radiology . , ... target a specific organ. However, when screening for ...
Breaking Medicine News(10 mins):Health News:Lung Infections May Hamper Ability to Detect Lung Cancer 2Health News:Inhabiting Eden: Christians, Scripture, and the Ecological Crisis – Public Lecture to Discuss Faith-Based Environmentalism 2Health News:'Brain Breaks' increase activity, educational performance in elementary schools 2Health News:'Brain Breaks' increase activity, educational performance in elementary schools 3Health News:Patients accept false-positives to achieve diagnostic sensitivity 2Health News:Patients accept false-positives to achieve diagnostic sensitivity 3
... Completes Renovation of Local ... Pediatrician,s Office, HOUSTON, Dec. ... Office Makeover" for pediatrician Dr.,Muhammad Shaikh at the Bissonet Medical Center ... initiative that AMERIGROUP Community,Care sponsored for the area,s physicians and its ...
... Aida,Pharmaceuticals (OTC Bulletin Board: AIDA) today ... has been named as a "New and,High-Tech ... New High,Technology Service Centre ("SNHTSC"), a special ... Government. This,designation will allow Rh-Apo2L to have ...
... and Treat Alzheimer,s Disease, MORGANTOWN, W.Va., Dec. 4 ... discovered that,a cancer drug - Bryostatin - enhances the ... This drug could potentially increase,normal memory capacity in humans ... disease, stroke and head trauma., In an article ...
... Proceeds Benefit Institute on Aging and the Center for ... Elderly Suicide Prevention (CESP), SAN ... at San Francisco,s War Memorial Veterans Building Green,Room, the Center for ... on Aging (IOA), celebrates their 21st Annual,Cable Car Caroling fundraising event. ...
... Capital Through 2010, LOUISVILLE, Ky., Dec. 4 Almost Family, ... terms of its,previously existing $22.5 million bank credit facility., ... in borrowings with a maturity date of June 2010. -- ... Earnings Before Interest Taxes Depreciation and Amortization ...
... Pa., Dec. 4 The Capital BlueCross Medicare,Advantage ... Keystone,Health Plan Central, was ranked as the No. ... a report issued today by the Pennsylvania,Health Care ... Containment Council is an independent state agency formed ...
Cached Medicine News:Health News:AMERIGROUP Community Care Provides 'Doctor's Office Makeover' in Houston 2Health News:Rh-Apo2L Named as One of China's High-Tech Transforming Products by Chinese Government 2Health News:Drug Found to Create New Connections in Brain, Restoring and Improving Memory 2Health News:Carolers Bring Holiday Cheer to Homebound Seniors 2Health News:Almost Family Announces Expansion of Revolving Credit Facility 2Health News:Almost Family Announces Expansion of Revolving Credit Facility 3Health News:Capital BlueCross HMO Plan is Ranked No. 1 in Pennsylvania for Member Satisfaction 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: